Small ubiquitin ‐like modifier/sentrin‐specific peptidase 1 associates with chemotherapy and is a risk factor for poor prognosis of non‐small cell lung cancer

Journal of Clinical Laboratory Analysis, EarlyView.

Source: Journal of Clinical Laboratory Analysis - July 25, 2018 Category: Laboratory Medicine Authors: Keyuan Liu , Jing Zhang , Hao Wang Source Type: research